Clinical Trial Update: Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

Phase 2 study comparing AR-13324 to Latanoprost in patients with elevated intraocular pressure has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AR-13324 (netarsudil)
• Latanoprost (Latanoprost)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2018-04-17